Table of Contents Asia-Pacific Ophthalmic Therapeutic Drugs Market Report 2018 1 Ophthalmic Therapeutic Drugs Overview 1.1 Product Overview and Scope of Ophthalmic Therapeutic Drugs 1.2 Classification of Ophthalmic Therapeutic Drugs by Product Category 1.2.1 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size (Sales) Comparison by Types (2013-2025) 1.2.2 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017 1.2.3 Anti-inflammatory Drugs 1.2.4 Anti-infective Drugs 1.2.5 Anti-glaucoma Drugs 1.2.6 Anti-allergy Drugs 1.2.7 Anti-VEGF Agents 1.2.8 Others 1.3 Asia-Pacific Ophthalmic Therapeutic Drugs Market by Application/End Users 1.3.1 Asia-Pacific Ophthalmic Therapeutic Drugs Sales (Volume) and Market Share Comparison by Applications (2013-2025) 1.3.2 Hospital Pharmacies 1.3.3 Online Pharmacies 1.3.4 Independent Pharmacies & Drug Stores 1.4 Asia-Pacific Ophthalmic Therapeutic Drugs Market by Region 1.4.1 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size (Value) Comparison by Region (2013-2025) 1.4.2 China Status and Prospect (2013-2025) 1.4.3 Japan Status and Prospect (2013-2025) 1.4.4 South Korea Status and Prospect (2013-2025) 1.4.5 Taiwan Status and Prospect (2013-2025) 1.4.6 India Status and Prospect (2013-2025) 1.4.7 Southeast Asia Status and Prospect (2013-2025) 1.4.8 Australia Status and Prospect (2013-2025) 1.5 Asia-Pacific Market Size (Value and Volume) of Ophthalmic Therapeutic Drugs (2013-2025) 1.5.1 Asia-Pacific Ophthalmic Therapeutic Drugs Sales and Growth Rate (2013-2025) 1.5.2 Asia-Pacific Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2013-2025) 2 Asia-Pacific Ophthalmic Therapeutic Drugs Competition by Players/Suppliers, Region, Type and Application 2.1 Asia-Pacific Ophthalmic Therapeutic Drugs Market Competition by Players/Suppliers 2.1.1 Asia-Pacific Ophthalmic Therapeutic Drugs Sales Volume and Market Share of Key Players/Suppliers (2013-2018) 2.1.2 Asia-Pacific Ophthalmic Therapeutic Drugs Revenue and Share by Players/Suppliers (2013-2018) 2.2 Asia-Pacific Ophthalmic Therapeutic Drugs (Volume and Value) by Type 2.2.1 Asia-Pacific Ophthalmic Therapeutic Drugs Sales and Market Share by Type (2013-2018) 2.2.2 Asia-Pacific Ophthalmic Therapeutic Drugs Revenue and Market Share by Type (2013-2018) 2.3 Asia-Pacific Ophthalmic Therapeutic Drugs (Volume) by Application 2.4 Asia-Pacific Ophthalmic Therapeutic Drugs (Volume and Value) by Region 2.4.1 Asia-Pacific Ophthalmic Therapeutic Drugs Sales and Market Share by Region (2013-2018) 2.4.2 Asia-Pacific Ophthalmic Therapeutic Drugs Revenue and Market Share by Region (2013-2018) 3 China Ophthalmic Therapeutic Drugs (Volume, Value and Sales Price) 3.1 China Ophthalmic Therapeutic Drugs Sales and Value (2013-2018) 3.1.1 China Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate (2013-2018) 3.1.2 China Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2013-2018) 3.1.3 China Ophthalmic Therapeutic Drugs Sales Price Trend (2013-2018) 3.2 China Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Type 3.3 China Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Application 4 Japan Ophthalmic Therapeutic Drugs (Volume, Value and Sales Price) 4.1 Japan Ophthalmic Therapeutic Drugs Sales and Value (2013-2018) 4.1.1 Japan Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate (2013-2018) 4.1.2 Japan Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2013-2018) 4.1.3 Japan Ophthalmic Therapeutic Drugs Sales Price Trend (2013-2018) 4.2 Japan Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Type 4.3 Japan Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Application 5 South Korea Ophthalmic Therapeutic Drugs (Volume, Value and Sales Price) 5.1 South Korea Ophthalmic Therapeutic Drugs Sales and Value (2013-2018) 5.1.1 South Korea Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate (2013-2018) 5.1.2 South Korea Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2013-2018) 5.1.3 South Korea Ophthalmic Therapeutic Drugs Sales Price Trend (2013-2018) 5.2 South Korea Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Type 5.3 South Korea Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Application 6 Taiwan Ophthalmic Therapeutic Drugs (Volume, Value and Sales Price) 6.1 Taiwan Ophthalmic Therapeutic Drugs Sales and Value (2013-2018) 6.1.1 Taiwan Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate (2013-2018) 6.1.2 Taiwan Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2013-2018) 6.1.3 Taiwan Ophthalmic Therapeutic Drugs Sales Price Trend (2013-2018) 6.2 Taiwan Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Type 6.3 Taiwan Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Application 7 India Ophthalmic Therapeutic Drugs (Volume, Value and Sales Price) 7.1 India Ophthalmic Therapeutic Drugs Sales and Value (2013-2018) 7.1.1 India Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate (2013-2018) 7.1.2 India Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2013-2018) 7.1.3 India Ophthalmic Therapeutic Drugs Sales Price Trend (2013-2018) 7.2 India Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Type 7.3 India Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Application 8 Southeast Asia Ophthalmic Therapeutic Drugs (Volume, Value and Sales Price) 8.1 Southeast Asia Ophthalmic Therapeutic Drugs Sales and Value (2013-2018) 8.1.1 Southeast Asia Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate (2013-2018) 8.1.2 Southeast Asia Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2013-2018) 8.1.3 Southeast Asia Ophthalmic Therapeutic Drugs Sales Price Trend (2013-2018) 8.2 Southeast Asia Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Type 8.3 Southeast Asia Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Application 9 Australia Ophthalmic Therapeutic Drugs (Volume, Value and Sales Price) 9.1 Australia Ophthalmic Therapeutic Drugs Sales and Value (2013-2018) 9.1.1 Australia Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate (2013-2018) 9.1.2 Australia Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2013-2018) 9.1.3 Australia Ophthalmic Therapeutic Drugs Sales Price Trend (2013-2018) 9.2 Australia Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Type 9.3 Australia Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Application 10 Asia-Pacific Ophthalmic Therapeutic Drugs Players/Suppliers Profiles and Sales Data 10.1 Bayer 10.1.1 Company Basic Information, Manufacturing Base and Competitors 10.1.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 10.1.2.1 Product A 10.1.2.2 Product B 10.1.3 Bayer Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.1.4 Main Business/Business Overview 10.2 Pfizer 10.2.1 Company Basic Information, Manufacturing Base and Competitors 10.2.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 10.2.2.1 Product A 10.2.2.2 Product B 10.2.3 Pfizer Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.2.4 Main Business/Business Overview 10.3 Novartis 10.3.1 Company Basic Information, Manufacturing Base and Competitors 10.3.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 10.3.2.1 Product A 10.3.2.2 Product B 10.3.3 Novartis Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.3.4 Main Business/Business Overview 10.4 ALLERGAN 10.4.1 Company Basic Information, Manufacturing Base and Competitors 10.4.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 10.4.2.1 Product A 10.4.2.2 Product B 10.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.4.4 Main Business/Business Overview 10.5 Aerie Pharmaceuticals 10.5.1 Company Basic Information, Manufacturing Base and Competitors 10.5.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 10.5.2.1 Product A 10.5.2.2 Product B 10.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.5.4 Main Business/Business Overview 10.6 Valeant Pharmaceuticals International 10.6.1 Company Basic Information, Manufacturing Base and Competitors 10.6.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 10.6.2.1 Product A 10.6.2.2 Product B 10.6.3 Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.6.4 Main Business/Business Overview 10.7 Genentech 10.7.1 Company Basic Information, Manufacturing Base and Competitors 10.7.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 10.7.2.1 Product A 10.7.2.2 Product B 10.7.3 Genentech Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.7.4 Main Business/Business Overview 10.8 Regeneron Pharmaceuticals 10.8.1 Company Basic Information, Manufacturing Base and Competitors 10.8.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 10.8.2.1 Product A 10.8.2.2 Product B 10.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.8.4 Main Business/Business Overview 10.9 Shire 10.9.1 Company Basic Information, Manufacturing Base and Competitors 10.9.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 10.9.2.1 Product A 10.9.2.2 Product B 10.9.3 Shire Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.9.4 Main Business/Business Overview 10.10 Santen Pharmaceutical 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 10.10.2.1 Product A 10.10.2.2 Product B 10.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.10.4 Main Business/Business Overview 11 Ophthalmic Therapeutic Drugs Manufacturing Cost Analysis 11.1 Ophthalmic Therapeutic Drugs Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.1.2 Price Trend of Key Raw Materials 11.1.3 Key Suppliers of Raw Materials 11.1.4 Market Concentration Rate of Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Manufacturing Process Analysis of Ophthalmic Therapeutic Drugs 12 Industrial Chain, Sourcing Strategy and Downstream Buyers 12.1 Ophthalmic Therapeutic Drugs Industrial Chain Analysis 12.2 Upstream Raw Materials Sourcing 12.3 Raw Materials Sources of Ophthalmic Therapeutic Drugs Major Manufacturers in 2017 12.4 Downstream Buyers 13 Marketing Strategy Analysis, Distributors/Traders 13.1 Marketing Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Development Trend 13.2 Market Positioning 13.2.1 Pricing Strategy 13.2.2 Brand Strategy 13.2.3 Target Client 13.3 Distributors/Traders List 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes Threat 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs/Customer Preference Change 14.3 Economic/Political Environmental Change 15 Asia-Pacific Ophthalmic Therapeutic Drugs Market Forecast (2018-2025) 15.1 Asia-Pacific Ophthalmic Therapeutic Drugs Sales Volume, Revenue and Price Forecast (2018-2025) 15.1.1 Asia-Pacific Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate Forecast (2018-2025) 15.1.2 Asia-Pacific Ophthalmic Therapeutic Drugs Revenue and Growth Rate Forecast (2018-2025) 15.1.3 Asia-Pacific Ophthalmic Therapeutic Drugs Price and Trend Forecast (2018-2025) 15.2 Asia-Pacific Ophthalmic Therapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025) 15.2.1 Asia-Pacific Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate Forecast by Region (2018-2025) 15.2.2 Asia-Pacific Ophthalmic Therapeutic Drugs Revenue and Growth Rate Forecast by Region (2018-2025) 15.2.3 China Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.4 Japan Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.5 South Korea Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.6 Taiwan Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.7 India Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.8 Southeast Asia Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.9 Australia Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.3 Asia-Pacific Ophthalmic Therapeutic Drugs Sales, Revenue and Price Forecast by Type (2018-2025) 15.3.1 Asia-Pacific Ophthalmic Therapeutic Drugs Sales Forecast by Type (2018-2025) 15.3.2 Asia-Pacific Ophthalmic Therapeutic Drugs Revenue Forecast by Type (2018-2025) 15.3.3 Asia-Pacific Ophthalmic Therapeutic Drugs Price Forecast by Type (2018-2025) 15.4 Asia-Pacific Ophthalmic Therapeutic Drugs Sales Forecast by Application (2018-2025) 16 Research Findings and Conclusion 17 Appendix 17.1 Methodology/Research Approach 17.1.1 Research Programs/Design 17.1.2 Market Size Estimation 17.1.3 Market Breakdown and Data Triangulation 17.2 Data Source 17.2.1 Secondary Sources 17.2.2 Primary Sources 17.3 Disclaimer

List of Tables and Figures Figure Product Picture of Ophthalmic Therapeutic Drugs Figure Asia-Pacific Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Type (2013-2025) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Sales Volume Market Share by Type (Product Category) in 2017 Figure Anti-inflammatory Drugs Product Picture Figure Anti-infective Drugs Product Picture Figure Anti-glaucoma Drugs Product Picture Figure Anti-allergy Drugs Product Picture Figure Anti-VEGF Agents Product Picture Figure Others Product Picture Figure Asia-Pacific Ophthalmic Therapeutic Drugs Sales (K Units) by Application (2013-2025) Figure Asia-Pacific Sales Market Share of Ophthalmic Therapeutic Drugs by Application in 2017 Figure Hospital Pharmacies Examples Table Key Downstream Customer in Hospital Pharmacies Figure Online Pharmacies Examples Table Key Downstream Customer in Online Pharmacies Figure Independent Pharmacies & Drug Stores Examples Table Key Downstream Customer in Independent Pharmacies & Drug Stores Figure Asia-Pacific Ophthalmic Therapeutic Drugs Market Size (Million USD) by Region (2013-2025) Figure China Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Japan Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure South Korea Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Taiwan Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure India Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Southeast Asia Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Australia Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Sales Volume (K Units) and Growth Rate (2013-2025) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Market Major Players Product Sales Volume (K Units)(2013-2018) Table Asia-Pacific Ophthalmic Therapeutic Drugs Sales (K Units) of Key Players/Suppliers (2013-2018) Table Asia-Pacific Ophthalmic Therapeutic Drugs Sales Share by Players/Suppliers (2013-2018) Figure 2017 Asia-Pacific Ophthalmic Therapeutic Drugs Sales Share by Players/Suppliers Figure 2017 Asia-Pacific Ophthalmic Therapeutic Drugs Sales Share by Players/Suppliers Figure Asia-Pacific Ophthalmic Therapeutic Drugs Market Major Players Product Revenue (Million USD) 2013-2018 Table Asia-Pacific Ophthalmic Therapeutic Drugs Revenue (Million USD) by Players/Suppliers (2013-2018) Table Asia-Pacific Ophthalmic Therapeutic Drugs Revenue Share by Players/Suppliers (2013-2018) Figure 2017 Asia-Pacific Ophthalmic Therapeutic Drugs Revenue Share by Players Figure 2017 Asia-Pacific Ophthalmic Therapeutic Drugs Revenue Share by Players Table Asia-Pacific Ophthalmic Therapeutic Drugs Sales and Market Share by Type (2013-2018) Table Asia-Pacific Ophthalmic Therapeutic Drugs Sales Share by Type (2013-2018) Figure Sales Market Share of Ophthalmic Therapeutic Drugs by Type (2013-2018) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Sales Growth Rate by Type (2013-2018) Table Asia-Pacific Ophthalmic Therapeutic Drugs Revenue (Million USD) and Market Share by Type (2013-2018) Table Asia-Pacific Ophthalmic Therapeutic Drugs Revenue Share by Type (2013-2018) Figure Revenue Market Share of Ophthalmic Therapeutic Drugs by Type (2013-2018) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Revenue Growth Rate by Type (2013-2018) Table Asia-Pacific Ophthalmic Therapeutic Drugs Sales Volume (K Units) and Market Share by Region (2013-2018) Table Asia-Pacific Ophthalmic Therapeutic Drugs Sales Share by Region (2013-2018) Figure Sales Market Share of Ophthalmic Therapeutic Drugs by Region (2013-2018) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Region in 2017 Table Asia-Pacific Ophthalmic Therapeutic Drugs Revenue (Million USD) and Market Share by Region (2013-2018) Table Asia-Pacific Ophthalmic Therapeutic Drugs Revenue Share (%) by Region (2013-2018) Figure Revenue Market Share of Ophthalmic Therapeutic Drugs by Region (2013-2018) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Revenue Market Share by Region in 2017 Table Asia-Pacific Ophthalmic Therapeutic Drugs Sales Volume (K Units) and Market Share by Application (2013-2018) Table Asia-Pacific Ophthalmic Therapeutic Drugs Sales Share (%) by Application (2013-2018) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Application (2013-2018) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Application (2013-2018) Figure China Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure China Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure China Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2013-2018) Table China Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Type (2013-2018) Table China Ophthalmic Therapeutic Drugs Sales Volume Market Share by Type (2013-2018) Figure China Ophthalmic Therapeutic Drugs Sales Volume Market Share by Type in 2017 Table China Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Applications (2013-2018) Table China Ophthalmic Therapeutic Drugs Sales Volume Market Share by Application (2013-2018) Figure China Ophthalmic Therapeutic Drugs Sales Volume Market Share by Application in 2017 Figure Japan Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure Japan Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure Japan Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2013-2018) Table Japan Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Type (2013-2018) Table Japan Ophthalmic Therapeutic Drugs Sales Volume Market Share by Type (2013-2018) Figure Japan Ophthalmic Therapeutic Drugs Sales Volume Market Share by Type in 2017 Table Japan Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Applications (2013-2018) Table Japan Ophthalmic Therapeutic Drugs Sales Volume Market Share by Application (2013-2018) Figure Japan Ophthalmic Therapeutic Drugs Sales Volume Market Share by Application in 2017 Figure South Korea Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure South Korea Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure South Korea Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2013-2018) Table South Korea Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Type (2013-2018) Table South Korea Ophthalmic Therapeutic Drugs Sales Volume Market Share by Type (2013-2018) Figure South Korea Ophthalmic Therapeutic Drugs Sales Volume Market Share by Type in 2017 Table South Korea Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Applications (2013-2018) Table South Korea Ophthalmic Therapeutic Drugs Sales Volume Market Share by Application (2013-2018) Figure South Korea Ophthalmic Therapeutic Drugs Sales Volume Market Share by Application in 2017 Figure Taiwan Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure Taiwan Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure Taiwan Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2013-2018) Table Taiwan Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Type (2013-2018) Table Taiwan Ophthalmic Therapeutic Drugs Sales Volume Market Share by Type (2013-2018) Figure Taiwan Ophthalmic Therapeutic Drugs Sales Volume Market Share by Type in 2017 Table Taiwan Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Applications (2013-2018) Table Taiwan Ophthalmic Therapeutic Drugs Sales Volume Market Share by Application (2013-2018) Figure Taiwan Ophthalmic Therapeutic Drugs Sales Volume Market Share by Application in 2017 Figure India Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure India Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure India Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2013-2018) Table India Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Type (2013-2018) Table India Ophthalmic Therapeutic Drugs Sales Volume Market Share by Type (2013-2018) Figure India Ophthalmic Therapeutic Drugs Sales Volume Market Share by Type in 2017 Table India Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Application (2013-2018) Table India Ophthalmic Therapeutic Drugs Sales Volume Market Share by Application (2013-2018) Figure India Ophthalmic Therapeutic Drugs Sales Volume Market Share by Application in 2017 Figure Southeast Asia Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure Southeast Asia Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure Southeast Asia Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2013-2018) Table Southeast Asia Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Type (2013-2018) Table Southeast Asia Ophthalmic Therapeutic Drugs Sales Volume Market Share by Type (2013-2018) Figure Southeast Asia Ophthalmic Therapeutic Drugs Sales Volume Market Share by Type in 2017 Table Southeast Asia Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Applications (2013-2018) Table Southeast Asia Ophthalmic Therapeutic Drugs Sales Volume Market Share by Application (2013-2018) Figure Southeast Asia Ophthalmic Therapeutic Drugs Sales Volume Market Share by Application in 2017 Figure Australia Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure Australia Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure Australia Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2013-2018) Table Australia Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Type (2013-2018) Table Australia Ophthalmic Therapeutic Drugs Sales Volume Market Share by Type (2013-2018) Figure Australia Ophthalmic Therapeutic Drugs Sales Volume Market Share by Type in 2017 Table Australia Ophthalmic Therapeutic Drugs Sales Volume (K Units) by Applications (2013-2018) Table Australia Ophthalmic Therapeutic Drugs Sales Volume Market Share by Application (2013-2018) Figure Australia Ophthalmic Therapeutic Drugs Sales Volume Market Share by Application in 2017 Table Bayer Ophthalmic Therapeutic Drugs Basic Information List Table Bayer Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Bayer Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure Bayer Ophthalmic Therapeutic Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Bayer Ophthalmic Therapeutic Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Pfizer Ophthalmic Therapeutic Drugs Basic Information List Table Pfizer Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Pfizer Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure Pfizer Ophthalmic Therapeutic Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Pfizer Ophthalmic Therapeutic Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Novartis Ophthalmic Therapeutic Drugs Basic Information List Table Novartis Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Novartis Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure Novartis Ophthalmic Therapeutic Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Novartis Ophthalmic Therapeutic Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table ALLERGAN Ophthalmic Therapeutic Drugs Basic Information List Table ALLERGAN Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure ALLERGAN Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure ALLERGAN Ophthalmic Therapeutic Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure ALLERGAN Ophthalmic Therapeutic Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Basic Information List Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Basic Information List Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Genentech Ophthalmic Therapeutic Drugs Basic Information List Table Genentech Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Genentech Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure Genentech Ophthalmic Therapeutic Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Genentech Ophthalmic Therapeutic Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Basic Information List Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Shire Ophthalmic Therapeutic Drugs Basic Information List Table Shire Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Shire Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure Shire Ophthalmic Therapeutic Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Shire Ophthalmic Therapeutic Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Santen Pharmaceutical Ophthalmic Therapeutic Drugs Basic Information List Table Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018) Figure Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2013-2018) Figure Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Santen Pharmaceutical Ophthalmic Therapeutic Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Production Base and Market Concentration Rate of Raw Material Figure Price (USD/Unit) Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Ophthalmic Therapeutic Drugs Figure Manufacturing Process Analysis of Ophthalmic Therapeutic Drugs Figure Ophthalmic Therapeutic Drugs Industrial Chain Analysis Table Raw Materials Sources of Ophthalmic Therapeutic Drugs Major Manufacturers in 2017 Table Major Buyers of Ophthalmic Therapeutic Drugs Table Distributors/Traders List Figure Asia-Pacific Ophthalmic Therapeutic Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Price (USD/Unit) and Trend Forecast (2018-2025) Table Asia-Pacific Ophthalmic Therapeutic Drugs Sales Volume (K Units) Forecast by Region (2018-2025) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Sales Volume Market Share Forecast by Region (2018-2025) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Sales Volume Market Share Forecast by Region in 2025 Table Asia-Pacific Ophthalmic Therapeutic Drugs Revenue (Million USD) Forecast by Region (2018-2025) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Region (2018-2025) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Region in 2025 Figure China Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2025) Figure China Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Japan Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2025) Figure Japan Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure South Korea Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2025) Figure South Korea Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Taiwan Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2025) Figure Taiwan Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure India Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2025) Figure India Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Southeast Asia Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2025) Figure Southeast Asia Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Australia Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2025) Figure Australia Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Table Asia-Pacific Ophthalmic Therapeutic Drugs Sales (K Units) Forecast by Type (2018-2025) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Type (2018-2025) Table Asia-Pacific Ophthalmic Therapeutic Drugs Revenue (Million USD) Forecast by Type (2018-2025) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Type (2018-2025) Table Asia-Pacific Ophthalmic Therapeutic Drugs Price (USD/Unit) Forecast by Type (2018-2025) Table Asia-Pacific Ophthalmic Therapeutic Drugs Sales (K Units) Forecast by Application (2018-2025) Figure Asia-Pacific Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Application (2018-2025) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources